Clinical Trials in Soshanguve, South Africa
3 recruiting
Showing 1–4 of 4 trials
Recruiting
Phase 1
Safety and Immunogenicity Study of Three mRNAs Encoding HIV Immunogens in Adult Participants Without HIV and in Overall Good Health in South Africa.
HIV Infections
International AIDS Vaccine Initiative96 enrolled6 locationsNCT06694753
Recruiting
Phase 1Phase 2
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
Urinary Tract Infections
GlaxoSmithKline448 enrolled8 locationsNCT06702449
Recruiting
Phase 2
Evaluating the Safety and Immunogenicity of MTBVAC
TuberculosisHIV I Infection
HIV Vaccine Trials Network276 enrolled16 locationsNCT05947890
Recruiting
Phase 2Phase 3
Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1
HIV-1-infection
Gilead Sciences75 enrolled21 locationsNCT06532656